3.1. epidemiology. bladder cancer (bc) seventh commonly diagnosed cancer male population worldwide, tenth genders considered . worldwide age-standardised incidence rate (per 100,000 person/years) 9.5 men 2.4 women . european union, age-standardised incidence rate 20 men 4.6 women . worldwide, bc age-standardised mortality rate (per 100,000 person/years) 3.3 men vs. 0.86 women . bladder cancer incidence mortality rates vary across countries due differences risk factors, detection diagnostic practices, variations access to, delivery of, healthcare. additionally, epidemiological variations attributed differing methodologies quality data individual datasets . incidence mortality bc decreased registries, possibly reflecting decreased impact causative factors . approximately 75% patients bc present disease confined mucosa (stage ta, cis) submucosa (stage t1); younger patients (< 40 years age) percentage even higher . patients tat1 cis high disease prevalence due long-term survival many cases lower risk cancer-specific mortality compared patients t2-4 disease .